Stay updated on Opregen in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 removed on the page; this is a minor metadata update and does not change study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added the label Last Update Posted (Estimated) next to the update timestamp to indicate the estimate.
    Difference
    0.1%
    Check dated 2025-12-30T22:46:37.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added multiple study locations across California, Florida, Maryland, Missouri, Ohio, Pennsylvania, Tennessee, Texas, Virginia, and Washington. Updated eligibility criteria to require BCVA between 29 and 60 ETDRS letters and OpRegen dosing up to approximately 200,000 cells; revision 3.3.3 and a new Last Update Posted timestamp were recorded.
    Difference
    2%
    Check dated 2025-12-23T21:09:01.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new 'Last Update Posted (Estimated)' field has been added to the Study Record Dates, and the previous 'Last Update Posted' field has been removed.
    Difference
    0.1%
    Check dated 2025-12-02T13:11:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added an auto-fill note for Publications indicating PubMed-derived articles may not be related to the study, and updated last update information and revision to v3.3.2; previous PubMed notes and an estimated update timestamp were removed.
    Difference
    0.4%
    Check dated 2025-11-25T10:34:45.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Removed the government funding status notice, a non-critical item, while core study details remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:18.000Z thumbnail image

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.